🇺🇸 FDA
Patent

US 10537581

Vaginal inserted estradiol pharmaceutical compositions and methods

granted A61KA61K31/565A61K31/57

Quick answer

US patent 10537581 (Vaginal inserted estradiol pharmaceutical compositions and methods) held by Compass Therapeutics LLC expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Therapeutics LLC
Grant date
Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/565, A61K31/57, A61K47/14, A61K9/0036